Balance Sheet HUTCHMED (China) Limited

Equities

HCM

KYG4672N1198

Pharmaceuticals

Market Closed - London S.E. Other stock markets 10:05:22 13/03/2026 pm IST			5-day change	1st Jan Change
210.00 ^GBX	+0.48%		-1.87%	+0.96%

06/03	BofA Securities Adjusts HUTCHMED Price Target to $21 From $22, Maintains Buy Rating	MT
06/03	Hutchmed Limited Announces Board Changes	CI

e076065849.yWlSJ5p5d8uz2TzEkGVRC31Kw6k-mDZpvYJ2nNYtZhk.pzgHafcVGP_Lq2i36jcjexR6nNtS_gUb_OE666VBH1utBwdk_D5O89SUVw

Published financial data: HUTCHMED (CHINA) LIMITED

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	36Cr	43Cr	84Cr	63Cr	55Cr
Total Revenues	36Cr	43Cr	84Cr	63Cr	55Cr
Cost of Goods Sold, Total	56Cr	70Cr	69Cr	56Cr	48Cr
Gross Profit	-20Cr	-27Cr	15Cr	6.92Cr	6.39Cr
Selling General & Admin Expenses, Total	13Cr	14Cr	13Cr	11Cr	10Cr
Other Operating Expenses, Total	13Cr	14Cr	13Cr	11Cr	10Cr
Operating Income	-33Cr	-41Cr	1.84Cr	-4.37Cr	-3.92Cr
Interest Expense, Total	-6L	-7L	-8L	-28.72L	-28.65L
Interest And Investment Income	20.76L	95.99L	3.61Cr	4.01Cr	4.99Cr
Net Interest Expenses	14.84L	89.47L	3.54Cr	3.72Cr	4.7Cr
Income (Loss) On Equity Invest.	6.06Cr	4.98Cr	4.73Cr	4.65Cr	2.27Cr
Currency Exchange Gains (Loss)	16.71L	-57.04L	86.61L	50.6L	49.98L
Other Non Operating Income (Expenses)	-1.19Cr	-59.72L	16.52L	51.34L	69.97L
EBT, Excl. Unusual Items	-28Cr	-36Cr	11Cr	5.02Cr	4.25Cr
Gain (Loss) On Sale Of Investments	12Cr	-	-	-	48Cr
Asset Writedown	-	-	-57.66L	-48.04L	-89T
EBT, Incl. Unusual Items	-16Cr	-36Cr	11Cr	4.54Cr	52Cr
Income Tax Expense	1.19Cr	-3L	45.09L	71.92L	6.36Cr
Earnings From Continuing Operations	-17Cr	-36Cr	10Cr	3.82Cr	46Cr
Net Income to Company	-17Cr	-36Cr	10Cr	3.82Cr	46Cr
Minority Interest	-2.76Cr	-4L	-3L	-4L	-8L
Net Income - (IS)	-19Cr	-36Cr	10Cr	3.77Cr	46Cr
Net Income to Common Incl Extra Items	-19Cr	-36Cr	10Cr	3.77Cr	46Cr
Net Income to Common Excl. Extra Items	-19Cr	-36Cr	10Cr	3.77Cr	46Cr
Per Share Items
Net EPS - Basic	-0.25	-0.43	0.12	0.04	0.53
Basic EPS - Continuing Operations	-0.25	-0.43	0.12	0.04	0.53
Basic Weighted Average Shares Outstanding	79Cr	85Cr	85Cr	86Cr	86Cr
Net EPS - Diluted	-0.25	-0.43	0.12	0.04	0.52
Diluted EPS - Continuing Operations	-0.25	-0.43	0.12	0.04	0.52
Diluted Weighted Average Shares Outstanding	79Cr	85Cr	87Cr	87Cr	87Cr
Normalized Basic EPS	-0.25	-0.27	0.08	0.04	0.03
Normalized Diluted EPS	-0.25	-0.27	0.08	0.04	0.03
American Depositary Receipts Ratio (ADR)	5	5	5	5	5
Supplemental Items
EBITDA	-32Cr	-40Cr	2.66Cr	-3.14Cr	-2.59Cr
EBITA	-33Cr	-41Cr	1.84Cr	-4.37Cr	-3.92Cr
EBIT	-33Cr	-41Cr	1.84Cr	-4.37Cr	-3.92Cr
EBITDAR	-32Cr	-39Cr	3.21Cr	-2.66Cr	-2.18Cr
Total Revenues (As Reported)	36Cr	43Cr	84Cr	63Cr	55Cr
Effective Tax Rate - (Ratio)	-7.68	0.08	4.27	15.85	12.2
Current Domestic Taxes	1.62Cr	28.81L	18.12L	17.23L	-
Current Foreign Taxes	4L	4L	5L	2L	-
Total Current Taxes	1.66Cr	32.8L	22.83L	18.84L	6.37Cr
Deferred Domestic Taxes	-47.18L	-35.63L	22.26L	53.08L	-
Total Deferred Taxes	-47.18L	-35.63L	22.26L	53.08L	-1L
Normalized Net Income	-20Cr	-23Cr	6.93Cr	3.09Cr	2.57Cr
Interest on Long-Term Debt	6L	7L	-	-	-
Supplemental Operating Expense Items
Selling and Marketing Expenses	3.78Cr	4.39Cr	5.34Cr	4.86Cr	3.63Cr
General and Administrative Expenses	8.93Cr	9.22Cr	7.98Cr	6.43Cr	6.67Cr
Research And Development Expense From Footnotes	31Cr	39Cr	30Cr	21Cr	15Cr
Net Rental Expense, Total	44.12L	53.72L	55.17L	47.49L	40.28L
Imputed Operating Lease Interest Expense	6L	8L	6L	12.4L	10L
Imputed Operating Lease Depreciation	38.57L	45.23L	49.25L	35.09L	30.44L
Stock-Based Comp., COGS (Total)	2.58Cr	2.14Cr	2.21Cr	1.45Cr	1.09Cr
Stock-Based Comp., G&A Exp. (Total)	-	-	-	-	-
Stock-Based Comp., SG&A Exp. (Total)	1.62Cr	91.79L	1.45Cr	70.7L	44.13L
Total Stock-Based Compensation	4.2Cr	3.06Cr	3.66Cr	2.16Cr	1.53Cr

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	38Cr	31Cr	28Cr	15Cr	7.13Cr
Short Term Investments	64Cr	32Cr	61Cr	68Cr	129.76Cr
Total Cash And Short Term Investments	101.45Cr	63Cr	89Cr	84Cr	136.89Cr
Accounts Receivable, Total	8.36Cr	9.8Cr	12Cr	16Cr	13Cr
Other Receivables	6.42Cr	2.87Cr	3.36Cr	1.39Cr	2.22Cr
Total Receivables	15Cr	13Cr	15Cr	17Cr	15Cr
Inventory	3.58Cr	5.67Cr	5.03Cr	5.04Cr	4.11Cr
Prepaid Expenses	1.41Cr	2.23Cr	71.08L	79.24L	83.39L
Deferred Tax Assets Current	-	-	-	-	-
Other Current Assets, Total	-	-	-	-	-
Total Current Assets	121.21Cr	84Cr	109.68Cr	106.66Cr	156.73Cr
Gross Property Plant And Equipment	8.61Cr	12Cr	15Cr	16Cr	17Cr
Accumulated Depreciation	-3.29Cr	-3.69Cr	-4.66Cr	-5.93Cr	-7.35Cr
Net Property Plant And Equipment	5.32Cr	8.47Cr	10Cr	9.7Cr	9.76Cr
Long-term Investments	7.65Cr	7.38Cr	4.84Cr	8.28Cr	1.09Cr
Goodwill	33.8L	-	-	-	31.12L
Other Intangibles, Total	2L	-	-	-	-
Deferred Tax Assets Long-Term	94.01L	1.54Cr	1.55Cr	1.24Cr	1.27Cr
Deferred Charges Long-Term	-	-	-	-	-
Other Long-Term Assets, Total	1.8Cr	1.57Cr	1.47Cr	1.54Cr	6.15Cr
Total Assets	137.27Cr	102.94Cr	127.98Cr	127.42Cr	175.31Cr
Liabilities
Accounts Payable, Total	4.12Cr	7.11Cr	3.63Cr	4.25Cr	4.55Cr
Accrued Expenses, Total	18Cr	23Cr	23Cr	21Cr	17Cr
Short-term Borrowings	-	-	3.12Cr	-	-
Current Portion of Long-Term Debt	2.69Cr	-	-	2.34Cr	2.5Cr
Current Portion of Leases	49.17L	37.08L	39.27L	29.25L	28.81L
Current Income Taxes Payable	1.55Cr	11.12L	25.8L	15.49L	20.83L
Unearned Revenue Current, Total	1.26Cr	1.4Cr	5.85Cr	6.17Cr	3.34Cr
Deferred Tax Liability Current	-	-	-	-	-
Other Current Liabilities	2.84Cr	3.72Cr	3.96Cr	3Cr	3.19Cr
Total Current Liabilities	31Cr	35Cr	40Cr	38Cr	32Cr
Long-Term Debt	-	1.81Cr	4.82Cr	5.94Cr	6.82Cr
Long-Term Leases	71.61L	51.96L	28.6L	40.89L	18.52L
Unearned Revenue Non Current	9L	-	6.95Cr	4.84Cr	2.01Cr
Deferred Tax Liability Non Current	27.65L	27.1L	14.84L	29.9L	3L
Other Non Current Liabilities	1.07Cr	1.27Cr	1.13Cr	1.08Cr	9.56Cr
Total Liabilities	33Cr	39Cr	54Cr	50Cr	50Cr
Common Stock, Total	8.65Cr	8.65Cr	8.71Cr	8.72Cr	8.72Cr
Additional Paid In Capital	150.52Cr	149.73Cr	152.24Cr	151.75Cr	153.39Cr
Retained Earnings	-61Cr	-97Cr	-87Cr	-83Cr	-38Cr
Comprehensive Income and Other	55.72L	-19.03L	-81.63L	-1.16Cr	-45.32L
Total Common Equity	99Cr	61Cr	73Cr	76Cr	123.79Cr
Minority Interest	5.26Cr	2.65Cr	1.28Cr	1.19Cr	1.33Cr
Total Equity	103.95Cr	64Cr	74Cr	77Cr	125.13Cr
Total Liabilities And Equity	137.27Cr	102.94Cr	127.98Cr	127.42Cr	175.31Cr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	86Cr	85Cr	85Cr	85Cr	86Cr
ECS Total Common Shares Outstanding	86Cr	85Cr	85Cr	85Cr	86Cr
Book Value / Share	1.15	0.72	0.86	0.89	1.44
Tangible Book Value	98Cr	61Cr	73Cr	76Cr	123.48Cr
Tangible Book Value Per Share	1.15	0.72	0.86	0.89	1.44
Total Debt	3.9Cr	2.7Cr	8.61Cr	8.98Cr	9.79Cr
Net Debt	-98Cr	-61Cr	-80Cr	-75Cr	-127.1Cr
Debt Equivalent Oper. Leases	3.53Cr	4.3Cr	4.41Cr	3.8Cr	3.22Cr
Minority Interest, Total (Incl. Fin. Div)	5.26Cr	2.65Cr	1.28Cr	1.19Cr	1.33Cr
Equity Method Investments, Total	7.65Cr	7.38Cr	4.84Cr	7.78Cr	1.09Cr
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	1.58Cr	2.74Cr	2.68Cr	2.43Cr	2.25Cr
Inventories - Finished Goods, Total	1.99Cr	2.93Cr	2.35Cr	2.61Cr	1.87Cr
Buildings, Total	24.32L	22.33L	5.67Cr	5.83Cr	6.11Cr
Machinery, Total	3.39Cr	3.92Cr	6.33Cr	6.8Cr	7.87Cr
Full Time Employees	1.76T	2.02T	1.99T	1.81T	1.8T
Accumulated Allowance for Doubtful Accounts (Supple)	20T	60T	2L	70T	3T

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	-19Cr	-36Cr	10Cr	3.77Cr	46Cr
Depreciation & Amortization - CF	71.9L	86.64L	82.07L	1.23Cr	1.33Cr
Amortization of Goodwill and Intangible Assets - (CF)	-	-	-	-	-
Depreciation & Amortization, Total	71.9L	86.64L	82.07L	1.23Cr	1.33Cr
Amortization of Deferred Charges, Total - (CF)	44T	18T	-	-	-
(Gain) Loss From Sale Of Asset	70T	1L	-10T	10T	-21T
(Gain) Loss on Sale of Investments - (CF)	-12Cr	1L	-45T	-	-48Cr
Asset Writedown & Restructuring Costs	-	-	57.66L	29.15L	89T
(Income) Loss On Equity Investments - (CF)	-6.06Cr	-4.98Cr	-4.73Cr	-4.65Cr	-2.27Cr
Stock-Based Compensation (CF)	4.2Cr	3.06Cr	3.66Cr	2.16Cr	1.53Cr
Provision and Write-off of Bad Debts	-76T	43T	1L	-98T	-75T
Other Operating Activities, Total	9.07Cr	4.37Cr	4.4Cr	3.46Cr	1.23Cr
Change In Accounts Receivable	-3.56Cr	-1.45Cr	-2.13Cr	-3.85Cr	2.89Cr
Change In Inventories	-1.6Cr	-2.12Cr	41.35L	-8L	95.42L
Change In Accounts Payable	95.65L	2.99Cr	-3.25Cr	61.94L	30.12L
Change in Unearned Revenues	1.11Cr	4L	12Cr	-2.6Cr	-4.96Cr
Change in Other Net Operating Assets	6.35Cr	6.4Cr	10.79L	-30.8L	-5.27Cr
Cash from Operations	-20Cr	-27Cr	22Cr	5L	-6.47Cr
Capital Expenditure	-1.64Cr	-3.67Cr	-3.26Cr	-1.79Cr	-1.41Cr
Sale of Property, Plant, and Equipment	-	-	-	-	28T
Cash Acquisitions	-	-	-	-	-
Divestitures	-	-	-29.9L	-	-
Sale (Purchase) of Real Estate properties	6L	-	-	12.78L	-
Sale (Purchase) of Intangible assets	-	-	-	-	-1Cr
Investment in Marketable and Equity Securities, Total	-28Cr	33Cr	-26Cr	-7.94Cr	-52.9L
Other Investing Activities, Total	-1.5Cr	-	-	-	-
Cash from Investing	-31Cr	30Cr	-29Cr	-9.61Cr	-2.94Cr
Long-Term Debt Issued, Total	-	1.78Cr	6.17Cr	3.62Cr	3.09Cr
Total Debt Issued	-	1.78Cr	6.17Cr	3.62Cr	3.09Cr
Short Term Debt Repaid, Total	-6L	-	-	-	-
Long-Term Debt Repaid, Total	-	-2.69Cr	-	-3.06Cr	-2.46Cr
Total Debt Repaid	-6L	-2.69Cr	-	-3.06Cr	-2.46Cr
Issuance of Common Stock	72Cr	2L	50.94L	8L	15.78L
Repurchase of Common Stock	-2.73Cr	-4.81Cr	-90.71L	-3.61Cr	-
Other Financing Activities, Total	-3.94Cr	-2.57Cr	-90.68L	-10L	-
Cash from Financing	65Cr	-8.28Cr	4.87Cr	-3.07Cr	78.36L
Foreign Exchange Rate Adjustments	24.27L	-94.9L	-64.71L	-34.01L	36.03L
Net Change in Cash	14Cr	-6.43Cr	-2.97Cr	-13Cr	-8.26Cr
Supplemental Items
Cash Interest Paid	4L	2L	4L	25.09L	25.18L
Cash Income Tax Paid (Refund)	50.14L	1.89Cr	37.28L	35.87L	6.24Cr
Levered Free Cash Flow	-15Cr	-19Cr	3.97Cr	-5.07Cr	-5.4Cr
Unlevered Free Cash Flow	-15Cr	-19Cr	4.02Cr	-4.9Cr	-5.22Cr
Change In Net Working Capital	-1.83Cr	-6.22Cr	-1.65Cr	3.77Cr	3.22Cr
Net Debt Issued / Repaid	-6L	-91.7L	6.17Cr	56.07L	62.58L

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	-19.57	-21.22	0.99	-2.14	-1.62
Return on Total Capital	-25.12	-29.25	1.54	-3.23	-2.21
Return On Equity %	-21.44	-43	14.65	5.04	45.25
Return on Common Equity	-26.46	-45.18	15.03	5.06	45.74
Margin Analysis
Gross Profit Margin %	-56.49	-63.69	18.08	10.98	11.64
SG&A Margin	35.7	31.92	15.89	17.92	18.78
EBITDA Margin %	-90.17	-93.58	3.17	-4.98	-4.71
EBITA Margin %	-92.19	-95.61	2.19	-6.94	-7.14
EBIT Margin %	-92.19	-95.61	2.19	-6.94	-7.14
Income From Continuing Operations Margin %	-46.9	-84.52	12.06	6.06	83.45
Net Income Margin %	-54.66	-84.62	12.03	5.99	83.3
Net Avail. For Common Margin %	-54.66	-84.62	12.03	5.99	83.3
Normalized Net Income Margin	-56.27	-52.97	8.27	4.91	4.69
Levered Free Cash Flow Margin	-43.36	-44.65	4.74	-8.05	-9.85
Unlevered Free Cash Flow Margin	-43.27	-44.56	4.79	-7.77	-9.52
Asset Turnover
Asset Turnover	0.34	0.36	0.73	0.49	0.36
Fixed Assets Turnover	8.35	6.19	8.86	6.26	5.64
Receivables Turnover (Average Receivables)	5.42	4.7	7.8	4.63	3.89
Inventory Turnover (Average Inventory)	20.08	15.1	12.84	11.15	10.59
Short Term Liquidity
Current Ratio	3.89	2.37	2.72	2.83	4.96
Quick Ratio	3.73	2.15	2.58	2.68	4.81
Operating Cash Flow to Current Liabilities	-0.66	-0.76	0.54	0	-0.2
Days Sales Outstanding (Average Receivables)	67.36	77.71	46.8	79.11	93.92
Days Outstanding Inventory (Average Inventory)	18.18	24.17	28.43	32.84	34.47
Average Days Payable Outstanding	23.17	28.51	28.83	25.71	33.8
Cash Conversion Cycle (Average Days)	62.37	73.38	46.4	86.23	94.58
Long Term Solvency
Total Debt/Equity	3.75	4.24	11.59	11.64	7.82
Total Debt / Total Capital	3.61	4.07	10.38	10.42	7.26
LT Debt/Equity	0.69	3.66	6.87	8.23	5.6
Long-Term Debt / Total Capital	0.66	3.51	6.15	7.37	5.19
Total Liabilities / Total Assets	24.27	38.13	41.91	39.42	28.63
EBIT / Interest Expense	-554.59	-625.3	24.21	-15.22	-13.67
EBITDA / Interest Expense	-534.99	-603.77	42.29	-9.27	-7.62
(EBITDA - Capex) / Interest Expense	-562.7	-660	-0.68	-15.51	-12.56
Total Debt / EBITDA	-0.12	-0.07	2.68	-3.37	-4.49
Net Debt / EBITDA	3.08	1.54	-25.01	28.14	58.24
Total Debt / (EBITDA - Capex)	-0.12	-0.06	-167.9	-2.02	-2.72
Net Debt / (EBITDA - Capex)	2.93	1.41	1.57T	16.81	35.33
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	56.21	19.73	96.52	-24.8	-12.96
Gross Profit, 1 Yr. Growth %	48.68	34.99	-155.8	-54.33	-7.72
EBITDA, 1 Yr. Growth %	68.48	24.26	-106.66	-217.99	-17.57
EBITA, 1 Yr. Growth %	66.94	24.18	-104.51	-337.85	-10.4
EBIT, 1 Yr. Growth %	66.94	24.18	-104.51	-337.85	-10.4
Earnings From Cont. Operations, 1 Yr. Growth %	44.6	115.75	-128.05	-62.24	1.1T
Net Income, 1 Yr. Growth %	54.81	85.38	-127.93	-62.56	1.11T
Normalized Net Income, 1 Yr. Growth %	152.39	12.72	-130.68	-55.39	-16.74
Diluted EPS Before Extra, 1 Yr. Growth %	36.31	73.46	-127.58	-66.28	1.2T
Accounts Receivable, 1 Yr. Growth %	74.6	17.24	19.29	33.06	-18.51
Inventory, 1 Yr. Growth %	80.89	58.55	-11.35	0.28	-18.39
Net Property, Plant and Equip., 1 Yr. Growth %	65.15	59.29	23.29	-7.09	0.68
Total Assets, 1 Yr. Growth %	89.56	-25	24.32	-0.44	37.58
Tangible Book Value, 1 Yr. Growth %	104.62	-38.15	19.69	4.02	63.13
Common Equity, 1 Yr. Growth %	103.85	-38.15	19.69	4.02	62.9
Cash From Operations, 1 Yr. Growth %	229.04	31.52	-181.63	-99.77	-13.11T
Capital Expenditures, 1 Yr. Growth %	106.33	123.55	-11.05	-45.01	-21.11
Levered Free Cash Flow, 1 Yr. Growth %	186.52	23.28	-120.75	-227.89	4.82
Unlevered Free Cash Flow, 1 Yr. Growth %	188.31	23.28	-121.05	-221.91	5
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	31.84	36.76	53.4	21.57	-19.1
Gross Profit, 2 Yr. CAGR %	46.73	41.67	-13.21	-49.52	-35.08
EBITDA, 2 Yr. CAGR %	50.68	44.69	-71.23	-71.96	-1.38
EBITA, 2 Yr. CAGR %	49.76	43.98	-76.34	-67.26	45.98
EBIT, 2 Yr. CAGR %	49.76	43.98	-76.34	-67.26	45.98
Earnings From Cont. Operations, 2 Yr. CAGR %	26.93	76.63	-22.21	-67.46	112.79
Net Income, 2 Yr. CAGR %	35.49	69.41	-28.04	-67.66	112.93
Normalized Net Income, 2 Yr. CAGR %	75.44	68.67	-41.19	-63.01	-39.05
Diluted EPS Before Extra, 2 Yr. CAGR %	24.17	53.77	-31.12	-69.5	109.38
Accounts Receivable, 2 Yr. CAGR %	39.01	43.07	18.26	25.99	4.13
Inventory, 2 Yr. CAGR %	48.53	69.35	18.56	-5.71	-9.54
Net Property, Plant and Equip., 2 Yr. CAGR %	41.97	62.19	40.14	7.03	-3.28
Total Assets, 2 Yr. CAGR %	71.79	19.23	-3.44	11.25	17.04
Tangible Book Value, 2 Yr. CAGR %	85.87	12.7	-13.96	11.58	30.01
Common Equity, 2 Yr. CAGR %	85.11	12.28	-13.96	11.58	30.17
Cash From Operations, 2 Yr. CAGR %	58.87	108.03	3.62	-95.7	-45.7
Capital Expenditures, 2 Yr. CAGR %	38.38	114.77	41.01	-30.06	-34.13
Levered Free Cash Flow, 2 Yr. CAGR %	31.7	87.94	-49.31	-48.48	16.67
Unlevered Free Cash Flow, 2 Yr. CAGR %	31.89	88.53	-48.95	-49.35	14.04
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	18.48	27.67	54.33	20.96	8.76
Gross Profit, 3 Yr. CAGR %	65.98	42.71	3.85	-29.93	-38.28
EBITDA, 3 Yr. CAGR %	53.35	41.3	-48.14	-53.95	-59.84
EBITA, 3 Yr. CAGR %	52.52	40.69	-54.62	-48.94	-54.2
EBIT, 3 Yr. CAGR %	52.46	40.69	-54.62	-48.94	-54.2
Earnings From Cont. Operations, 3 Yr. CAGR %	32.82	51.48	-4.35	-38.86	8.3
Net Income, 3 Yr. CAGR %	37.54	50.42	-7.11	-42.13	8.19
Normalized Net Income, 3 Yr. CAGR %	63.8	51.39	-4.43	-46.37	-51.52
Diluted EPS Before Extra, 3 Yr. CAGR %	29.67	38.81	-13	-45.71	6.54
Accounts Receivable, 3 Yr. CAGR %	24.84	31.34	34.66	23	8.96
Inventory, 3 Yr. CAGR %	42.68	51.8	36.49	12.12	-10.14
Net Property, Plant and Equip., 3 Yr. CAGR %	47.35	47.53	48.02	22.2	4.87
Total Assets, 3 Yr. CAGR %	37.15	30.32	20.9	-2.45	19.42
Tangible Book Value, 3 Yr. CAGR %	36.64	28.96	14.98	-8.34	26.47
Common Equity, 3 Yr. CAGR %	36.39	28.45	14.7	-8.34	26.58
Cash From Operations, 3 Yr. CAGR %	83.88	49.18	52.3	-86.55	-37.79
Capital Expenditures, 3 Yr. CAGR %	37.1	62.37	60.09	3.02	-27.2
Levered Free Cash Flow, 3 Yr. CAGR %	68.04	28.83	-9.71	-30.99	-34.38
Unlevered Free Cash Flow, 3 Yr. CAGR %	68.89	28.96	-9.09	-31.77	-35.07
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	10.51	12.07	31.38	25.2	19.2
Gross Profit, 5 Yr. CAGR %	95.09	93.01	28.06	-5.83	-13.94
EBITDA, 5 Yr. CAGR %	48.57	50.99	-21.48	-26.01	-32.94
EBITA, 5 Yr. CAGR %	47.77	50.21	-27.63	-21.48	-27.59
EBIT, 5 Yr. CAGR %	47.71	50.15	-27.64	-21.48	-27.59
Earnings From Cont. Operations, 5 Yr. CAGR %	62.91	73.44	7.24	-18.11	31.7
Net Income, 5 Yr. CAGR %	75.48	68.28	6.14	-18.67	29.44
Normalized Net Income, 5 Yr. CAGR %	86.23	69.38	8.73	-13.84	-20.17
Diluted EPS Before Extra, 5 Yr. CAGR %	65.82	57.95	1.04	-24.15	23.62
Accounts Receivable, 5 Yr. CAGR %	12.79	18.31	22.17	29.17	21.5
Inventory, 5 Yr. CAGR %	22.77	36.9	32.49	25.47	15.78
Net Property, Plant and Equip., 5 Yr. CAGR %	39.8	42.88	44.42	29.76	24.85
Total Assets, 5 Yr. CAGR %	32.01	11.48	19.19	22.33	19.34
Tangible Book Value, 5 Yr. CAGR %	40.34	5.91	13.64	21.7	20.77
Common Equity, 5 Yr. CAGR %	39.88	5.74	13.43	21.42	20.66
Cash From Operations, 5 Yr. CAGR %	84.44	97.48	46.18	-63.89	0.82
Capital Expenditures, 5 Yr. CAGR %	30.54	48.84	38.65	15.93	12.22
Levered Free Cash Flow, 5 Yr. CAGR %	59.15	34.31	4.04	-10.63	0.04
Unlevered Free Cash Flow, 5 Yr. CAGR %	61.11	34.73	4.65	-11.19	-0.46